Neel Shah

Neel Shah

Amgen Inc - Thousand Oaks / United States
Others
AD Scientific Index ID: 4888473
-
person_outline Neel Shah's MOST POPULAR ARTICLES
1-) Treatment Patterns and Annual Drug Costs of Biologic Therapies Across Indications from the Humana Commercial DatabaseA Howe, L Ten Eyck, R Dufour, N Shah, DJ HarrisonJ Manag Care Pharm 20 (12), 1236-44, 2014582014
2-) Etanercept-methotrexate combination therapy initiators have greater adherence and persistence than triple therapy initiators with rheumatoid arthritis.CDH Bonafede M, Johnson BH, Tang DH, Shah N, Harrison DJArthritis Care Res, 2015372015
3-) Living post treatment: definitions of those with history and no history of cancerKM Kelly, N Shah, R Shedlosky-Shoemaker, K Porter, D AgneseJournal of Cancer Survivorship 5 (2), 158-166, 2011322011
4-) Cost of biologics per treated patient across immune-mediated inflammatory disease indications in a pharmacy benefit management setting: a retrospective cohort studyN Wu, N Shah, DJ HarrisonClinical therapeutics 36 (8), 1231-1241. e3, 2014322014
5-) Cost per patient-year in response using a claims-based algorithm for the 2 years following biologic initiation in patients with rheumatoid arthritisM Bonafede, BH Johnson, N Princic, N Shah, DJ HarrisonJournal of medical economics 18 (5), 376-389, 2015242015